Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theonie Anastassiadis

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|September 13, 2023
Ushering in the era of tRNA medicinesTheonie Anastassiadis, Caroline Köhrer
Cancer Cell|February 15, 2014
Wild-type RAS: keeping mutant RAS in CHKTheonie Anastassiadis, Eric J Brown
Nature Biotechnology|November 1, 2011
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivityTheonie Anastassiadis, Sean W Deacon, Karthik Devarajan, et al.
Molecular Cell|November 13, 2010
Phosphoinositides are essential coactivators for p21-activated kinase 1Todd I Strochlic, Julien Viaud, Ulrike E E Rennefahrt, et al.
The Journal of Biological Chemistry|August 13, 2013
A highly selective dual insulin receptor (IR)/insulin-like growth factor 1 receptor (IGF-1R) inhibitor derived from an extracellular signal-regulated kinase (ERK) inhibitorTheonie Anastassiadis, Krisna C Duong-Ly, Sean W Deacon, et al.
Neuro-Oncology|June 4, 2011
Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapiesDemirkan B Gürsel, Yvette S Connell-Albert, Robert G Tuskan, et al.
Molecular Cell|October 9, 2018
Genome-wide Identification of Structure-Forming Repeats as Principal Sites of Fork Collapse upon ATR InhibitionNishita Shastri, Yu-Chen Tsai, Suzanne Hile, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|September 13, 2023
Ushering in the era of tRNA medicinesTheonie Anastassiadis, Caroline Köhrer
Cancer Cell|February 15, 2014
Wild-type RAS: keeping mutant RAS in CHKTheonie Anastassiadis, Eric J Brown
Nature Biotechnology|November 1, 2011
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivityTheonie Anastassiadis, Sean W Deacon, Karthik Devarajan, et al.
Molecular Cell|November 13, 2010
Phosphoinositides are essential coactivators for p21-activated kinase 1Todd I Strochlic, Julien Viaud, Ulrike E E Rennefahrt, et al.
The Journal of Biological Chemistry|August 13, 2013
A highly selective dual insulin receptor (IR)/insulin-like growth factor 1 receptor (IGF-1R) inhibitor derived from an extracellular signal-regulated kinase (ERK) inhibitorTheonie Anastassiadis, Krisna C Duong-Ly, Sean W Deacon, et al.
Neuro-Oncology|June 4, 2011
Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapiesDemirkan B Gürsel, Yvette S Connell-Albert, Robert G Tuskan, et al.
Molecular Cell|October 9, 2018
Genome-wide Identification of Structure-Forming Repeats as Principal Sites of Fork Collapse upon ATR InhibitionNishita Shastri, Yu-Chen Tsai, Suzanne Hile, et al.
Pageof 1